Synovics Pharmaceuticals, Inc.
SYVC
$0.00
$0.000.00%
OTC PK
| 07/31/2009 | 04/30/2009 | 01/31/2009 | 10/31/2008 | 07/31/2008 | |
|---|---|---|---|---|---|
| Net Income | -512.68% | 11.85% | 50.51% | 115.85% | 106.54% |
| Total Depreciation and Amortization | 39.96% | -4.87% | 5.43% | -24.08% | 4.98% |
| Total Amortization of Deferred Charges | -98.71% | 146.83% | -5.52% | 362.59% | 311.57% |
| Total Other Non-Cash Items | -88.21% | -95.68% | -- | -66.15% | -74.63% |
| Change in Net Operating Assets | 178.73% | 677.82% | -67.23% | -183.34% | -287.38% |
| Cash from Operations | -97.51% | 113.88% | -26.99% | 459.97% | 312.68% |
| Capital Expenditure | 86.66% | 101.38% | 62.83% | -196.91% | -116.55% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 86.66% | 101.38% | 62.83% | -132.49% | 19.06% |
| Total Debt Issued | 1,146.03% | -- | -- | -100.00% | -109.84% |
| Total Debt Repaid | 84.73% | 86.00% | 13.03% | 56.43% | -3,454.57% |
| Issuance of Common Stock | -- | -- | -- | -- | 5,546.85% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 106.01% | -112.75% | 13.03% | 42.42% | -254.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -70.16% | -149.28% | -4,740.00% | 85.86% | 192.33% |